Alpine Immune Sciences, Inc. (ALPN) SEC filings
ALPN SEC filings moved a median of -0.03% by the close. ALPN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ALPN overview →
21 measured ALPN SEC filing events.
Where these ALPN SEC filings landedvs 16 measured ALPN SEC filing reactions
| Middle 50% of ALPN SEC filing reactions | -0.94% to +4.84% |
|---|---|
| Median reaction (to close) | -0.03% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 ALPN SEC filing events with a measured close landed between -0.94% and +4.84%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G ALPINE IMMUNE SCIENCES, | SEC filing · Form 15-12G | — | — | |
| Form EFFECT ALPINE IMMUNE SCIENCES, | SEC filing · Form EFFECT | — | — | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: May 17 | SEC filing · Form 8-K | — | — | |
| Form POS AM ALPINE IMMUNE SCIENCES, | SEC filing · Form POS | — | — | |
| Form S-8 POS ALPINE IMMUNE SCIENCES, | SEC filing · Form S-8 | — | — | |
| Form 10-Q ALPINE IMMUNE SCIENCES, For: Mar 31 | SEC filing · Form 10-Q | -0.01% | +0.00% | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: May 09 | SEC filing · Form 8-K | -0.01% | +0.00% | |
| Form 10-K/A ALPINE IMMUNE SCIENCES, For: Dec 31 | SEC filing · Form 10-K | -0.01% | -0.06% | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: Apr 10 | SEC filing · Form 8-K | -0.02% | +0.34% | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: Apr 03 | SEC filing · Form 8-K | +0.17% | +10.62% | |
| Form 10-K ALPINE IMMUNE SCIENCES, For: Dec 31 | SEC filing · Form 10-K | +2.31% | -0.15% | |
| Form S-8 ALPINE IMMUNE SCIENCES, | SEC filing · Form S-8 | +2.31% | -0.15% | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: Mar 18 | SEC filing · Form 8-K | +7.29% | +6.82% | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: Feb 02 | SEC filing · Form 8-K | -0.17% | +4.56% | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: Jan 04 | SEC filing · Form 8-K | -0.84% | +5.67% | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: Dec 20 | SEC filing · Form 8-K | +0.52% | -3.77% | |
| Form 10-Q ALPINE IMMUNE SCIENCES, For: Sep 30 | SEC filing · Form 10-Q | +3.22% | -0.94% | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: Nov 14 | SEC filing · Form 8-K | +3.22% | -0.94% | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: Nov 06 | SEC filing · Form 8-K | -0.51% | -2.54% | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: Nov 06 | SEC filing · Form 8-K | -1.19% | -11.69% | |
| Form 8-K ALPINE IMMUNE SCIENCES, For: Nov 02 | SEC filing · Form 8-K | -0.81% | +8.63% |
Keep exploring
More ALPN: earnings → · analyst actions → · ALPN overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Exicure, Inc. (XCUR) | 173 | 0.00% | 49% |
| Aytu BioPharma, Inc. (AYTU) | 172 | -0.14% | 40% |
| NuCana plc - American Depositary Shares (NCNA) | 171 | -1.28% | 40% |
| UCB SA NPV (UCBJF) | 171 | 0.00% | 3% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.